Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
PZ HTL SA
GLOBETECH PUBLISHING

Research Grant to Fund Development of Novel Tumor-Imaging Nanoprobes

By BiotechDaily International staff writers
Posted on 04 Nov 2013
Research funds have been awarded that will support a collaborative effort to develop novel nanoprobes to be used for in vivo tumor imaging.

Rockland Immunochemicals Inc. (Gilbertsville, PA, USA) and Abzyme Therapeutics (Malvern, PA, USA) have received a Phase I Small Business Innovation Research (SBIR) grant from the [US] National Cancer Institute (Bethesda, MD, USA) to develop nanoprobes for in vivo imaging of tumors that express the important cancer therapeutic targets: EGFR (epidermal growth factor receptor), Her2 (human epidermal growth factor receptor 2), or mesothelin.

According to the terms of the grant, during the first phase the partners will develop, label, and characterize high-affinity single domain antibodies against the three tumor antigens. Abzyme Therapeutics will develop the single domain antibodies, and Rockland will be responsible for bioconjugation and in vivo characterization.

In the planned second phase of the project, the key antibodies will be labeled with a radioactive isotope and characterized using PET scanners in collaboration with Yale University (New Haven, CT, USA) and the University of Pittsburg (PA, USA). Suitable radioactively labeled antibodies will be used as in vivo imaging agents, and their potential use in targeted cancer therapy will be considered.

“In these times of shrinking government investment in research, this SBIR grant validates Rockland’s business model of collaboration with leading academic institutions to aggregate, develop, and commercialize technologies that will ultimately benefit humanity,” said Jim Fendrick, president and CEO of Rockland Immunochemicals. “This research is in line with the company’s expertise in antibodies and antibody based tools. We are confident that this collaboration will generate significant innovation and that the results will have great scientific and commercial applications.”

According to the market research firm Markets and Markets (Pune, India), the global diagnostic imaging market, which stood at USD 20.7 billion in 2010, is expected to expand to USD 26.6 billion by 2016. This expected rise is attributed to an aging population, increasing awareness about preventive care, and advancements in the field.

Related Links:
Rockland Immunochemicals Inc.
Abzyme Therapeutics
[US] National Cancer Institute




Channels

Genomics/Proteomics

view channel
Image: The TheraCyte cell encapsulation device (Photo courtesy of TheraCyte, Inc.).

Encapsulated Human-Insulin-Producing Progenitor Cells Cure Diabetes in Mouse Model

A breakthrough system that allows subcutaneous implantation of encapsulated immature pancreatic cells (beta progenitor cells) was shown to produce enough insulin to correct the symptoms of diabetes in a mouse model.... Read more

Drug Discovery

view channel
Image: Chitosan is derived from the shells of shrimp and other sea crustaceans, including Alaskan pink shrimp, pictured here (Photo courtesy of NOAA - [US] National Oceanic and Atmospheric Administration).

Chitosan Treatment Clears the Way for Antibiotics to Eliminate Recurrent Urinary Tract Infections

Recurrent urinary tract infection was successfully resolved in a mouse model by treatment with the exfoliant chitosan followed by a round of antibiotics. Bacterial urinary tract infection (UTI), most... Read more

Biochemistry

view channel

Mitochondrial Cause of Aging Can Be Reversed

Researchers have found a cause of aging in lab animals that can be reversed, possibly providing an avenue for new treatments for age-related diseases including type 2 diabetes, cancer, muscle wasting, and inflammatory diseases. The researchers plan to begin human trials late 2014. The study, which was published December... Read more

Therapeutics

view channel

Cytokine Identified That Causes Mucositis in Cancer Therapy Patients

The action of the cytokine interleukin 1-beta (IL-1beta) has been found to underlie the onset of mucositis, a common, severe side effect of chemotherapy and irradiation of cancer patients. Mucositis occurs as a result of cell death in reaction to chemo- or radiotherapy. The mucosal lining of the mouth becomes thin, may... Read more

Business

view channel

Analytical Sciences Trade Fair Declared a Rousing Success

Organizers of this year's 24th "analytica" biosciences trade fair have reported significant increases in both the number of visitors and exhibitors compared to the 2012 event. The analytica trade fair for laboratory technology, analysis, and biotechnology has been held at the Munich (Germany) Trade Fair Center every... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.